AR054015A1 - Soluciones para dialisis peritoneal que tienen mayor biocompatibilidad - Google Patents

Soluciones para dialisis peritoneal que tienen mayor biocompatibilidad

Info

Publication number
AR054015A1
AR054015A1 ARP060100884A ARP060100884A AR054015A1 AR 054015 A1 AR054015 A1 AR 054015A1 AR P060100884 A ARP060100884 A AR P060100884A AR P060100884 A ARP060100884 A AR P060100884A AR 054015 A1 AR054015 A1 AR 054015A1
Authority
AR
Argentina
Prior art keywords
peritoneal dialysis
carnitine
solutions
peritoneum
solution
Prior art date
Application number
ARP060100884A
Other languages
English (en)
Spanish (es)
Inventor
Arduino Arduini
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Publication of AR054015A1 publication Critical patent/AR054015A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/20—Elemental chlorine; Inorganic compounds releasing chlorine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • External Artificial Organs (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ARP060100884A 2005-03-10 2006-03-09 Soluciones para dialisis peritoneal que tienen mayor biocompatibilidad AR054015A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2005000130 2005-03-10

Publications (1)

Publication Number Publication Date
AR054015A1 true AR054015A1 (es) 2007-05-30

Family

ID=35159907

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP060100884A AR054015A1 (es) 2005-03-10 2006-03-09 Soluciones para dialisis peritoneal que tienen mayor biocompatibilidad

Country Status (19)

Country Link
US (1) US20080138443A1 (OSRAM)
EP (1) EP1858504B1 (OSRAM)
JP (2) JP4717110B2 (OSRAM)
KR (1) KR101324920B1 (OSRAM)
AR (1) AR054015A1 (OSRAM)
AT (1) ATE539742T1 (OSRAM)
CA (1) CA2599252C (OSRAM)
CY (1) CY1112794T1 (OSRAM)
DK (1) DK1858504T3 (OSRAM)
ES (1) ES2380168T3 (OSRAM)
HR (1) HRP20120177T1 (OSRAM)
ME (1) ME02948B (OSRAM)
MX (1) MX2007010814A (OSRAM)
PL (1) PL1858504T3 (OSRAM)
PT (1) PT1858504E (OSRAM)
RS (1) RS52237B (OSRAM)
SI (1) SI1858504T1 (OSRAM)
TW (1) TWI388318B (OSRAM)
WO (1) WO2006094900A1 (OSRAM)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2365429B1 (es) * 2010-03-05 2012-09-06 Universidad De Castilla De La Mancha Solucion para dialisis peritoneal
US20190183927A1 (en) * 2016-08-11 2019-06-20 Sulfilatec, Inc. Medical and nutritional compositions and methods of use
ES2750642A1 (es) * 2018-09-26 2020-03-26 Univ Vigo Composición farmacéutica que comprende proteína amiloide P de suero para tratar la insuficiencia renal aguda o crónica
EP3912656A1 (en) 2020-05-19 2021-11-24 CoreQuest Sagl Peritoneal dialysis solution

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5126373A (en) 1987-11-19 1992-06-30 Henri Brunengraber Composition for parenteral and oral nutrition
JPH08131542A (ja) * 1994-11-11 1996-05-28 Baxter Kk 腹膜透析液調製用溶液セット
CA2155910C (en) 1995-08-11 1999-12-14 George Wu Biocompatible aqueous solution for use in continuous ambulatory peritoneal dialysis
GB9714218D0 (en) * 1997-07-04 1997-09-10 Allied Therapeutics Ltd Peritoneal dialysis fluid
WO1999007419A1 (en) 1997-08-07 1999-02-18 Ajay Gupta Dialysis solutions containing water soluble vitamins and nutrients
DE19748290B8 (de) 1997-10-31 2009-09-03 Fresenius Medical Care Deutschland Gmbh Lösung für die Peritonealdialyse
AU1073400A (en) 1999-10-11 2001-04-23 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Use of l-carnitine and its alkanoyl derivatives as osmotic agents in solutions for medical use
JP2002282354A (ja) 2001-03-27 2002-10-02 Jms Co Ltd 腹膜透析液
GB0108359D0 (en) * 2001-04-03 2001-05-23 Allied Therapeutics Ltd Peritoneal dialysis fluid
ITRM20010337A1 (it) * 2001-06-14 2002-12-16 Sigma Tau Ind Farmaceuti Soluzione per la conservazione e perfuzione di organi in attesa che vengano trapiantati.
FR2840612B1 (fr) * 2002-06-06 2005-05-06 Roquette Freres Polymeres solubles de glucose hautement branches et leur procede d'obtention
JP2004016615A (ja) * 2002-06-19 2004-01-22 Fuso Pharmaceutical Industries Ltd 晶質浸透圧剤及び膠質浸透圧剤を含有する腹膜透析液
JP4361493B2 (ja) 2002-12-10 2009-11-11 ガンブロ・ルンディア・エービー 腹膜透析用薬剤の製造のための医学的溶液を調製する方法
JP2006075195A (ja) * 2004-09-07 2006-03-23 Jms Co Ltd Lカルニチン含有腹膜透析液

Also Published As

Publication number Publication date
EP1858504B1 (en) 2012-01-04
JP4717110B2 (ja) 2011-07-06
MX2007010814A (es) 2007-11-07
US20080138443A1 (en) 2008-06-12
PT1858504E (pt) 2012-04-10
ME02948B (me) 2012-10-31
CA2599252C (en) 2013-07-30
JP2008532601A (ja) 2008-08-21
TWI388318B (zh) 2013-03-11
TW200714279A (en) 2007-04-16
RS52237B (sr) 2012-10-31
SI1858504T1 (sl) 2012-04-30
DK1858504T3 (da) 2012-04-30
ES2380168T3 (es) 2012-05-09
PL1858504T3 (pl) 2012-05-31
JP2010207630A (ja) 2010-09-24
EP1858504A1 (en) 2007-11-28
KR20070116630A (ko) 2007-12-10
HRP20120177T1 (hr) 2012-03-31
KR101324920B1 (ko) 2013-11-01
JP5366894B2 (ja) 2013-12-11
WO2006094900A1 (en) 2006-09-14
CY1112794T1 (el) 2016-02-10
CA2599252A1 (en) 2006-09-14
ATE539742T1 (de) 2012-01-15

Similar Documents

Publication Publication Date Title
CO6290622A2 (es) Composiciones de activo antitranspirante con un cromatograma sec que presenta una elevada intensidad de pico 4 sec para reducir la transpiración
AR062046A1 (es) Soluciones oftalmicas
ES2537539T3 (es) Composición oftálmica
AR054227A1 (es) Composicion de principios activos
CL2020000293A1 (es) Gel que comprende clorhexidina.
AR052428A1 (es) Composicion contra las caries para el cuidado oral con xilitol
CL2009000625A1 (es) Composicion farmaceutica que comprende a)un primer poliol seleccionado de manitol, sorbitol o una combinacion de ambos, b)segundo poliol seleccionado de propilenglicol, glicerina o una combinacion de ambas, c)complejo de borato en un 0,5% p/v de la composicion total, d)preservante, e)agua; util para el tratamiento del ojo.
CL2008003762A1 (es) Composicion concentrada en suspension acuosa para proteccion de cultivos, que comprende un compuesto activo y como agentes estabilizadores, un disperzante no ionico y un dsipersante anionico y agua; metodos para preparacion de dicha composicion y usos de la misma, para el cuidado de cultivos de interes.
ECSP055702A (es) Administración de sales de anfetamina de liberación sostenida
AR081983A1 (es) Articulo de dosis unitaria soluble que comprende un polimero cationico
CL2011000170A1 (es) Composicion farmaceutica solida y estabilizada que comprende un ingrediente farmaceuticamente activo, oxido de titanio y un plastificante; procedimiento para estabilizar la composicion farmaceutica durante una irradiacion luminosa.
PE20071310A1 (es) Formulaciones liquidas de fenilefrina
GT200900284A (es) Dosis intravenosa y oral de un inhibidor p2y12 de accion directa y reversible.-
PE20060002A1 (es) Combinaciones antineoplasicas de cci-779 y rituximab
AR071183A1 (es) Composicion oral que comprende un componente activo y un componente formador de pelicula adhesiva, metodo
AR074841A1 (es) Composicion que comprende aceite de canamo para tratar enfermedades topicas, especialmente el sindrome mano-pie
CO5251448A1 (es) Soluciones que contienen epinastina
AR068081A1 (es) Metodo mejorado para el tratamiento de productos agricolas, alimenticios y piensos con un compuestos antifungico de polieno
AR075909A1 (es) Un articulo absorbente.
PY1717949A (es) Composiciones, kits y métodos para mantener la higiene de los párpados
AR095681A2 (es) Una solución acuosa desinfectante no terapéutica, un método para prepararla, una preparación desinfectante y un método para desinfectar o esterilizar un objeto
UY28357A1 (es) Derivados de benzimidazol, composiciones que los contienen, preparación de los mismos y sus usos
ES2581331T3 (es) Inhibidor de la progresión de una enfermedad atribuida a una acumulación anormal de grasa hepática
CY1112794T1 (el) Διαλυμα περιτοναϊκης αιμοκαθαρσης που περιεχει καρνιτινη το οποιο εχει βελτιωμενη βιοσυμβατοτητα
AR052855A1 (es) Composiciones para el cuidado bucal que contienen un extrato de eucalyptus

Legal Events

Date Code Title Description
FB Suspension of granting procedure